期刊文献+

护骨素基因启动子区T^(950)-C多态性与骨密度及骨代谢的关系 被引量:13

Relationships among single T^(950) -C mutation polymorphism in the promoter region of the osteoprotegerin gene, bone mineral density and metabolism
下载PDF
导出
摘要 目的探讨绝经后汉族妇女护骨素(OPG)基因启动子区T950C多态性与骨质疏松症和骨代谢的关系。方法应用PCRRFLP测定随机选取的73例绝经后骨质疏松症妇女和61例绝经后正常妇女OPG基因T950C的基因型,双能X线骨吸收方法分别测腰椎各椎体和股骨颈髋部的BMD,放射免疫分析法测骨代谢指标。结果所选人群OPG基因T950C基因型频率分布在骨质疏松症和绝经正常妇女均符合HardyWeinberg定律,而且其基因型在两组研究对象中分布差异无显著性,但汉族妇女T950C基因型分布与高加索人种妇女相比有明显差异。在骨质疏松症组CC型的股骨颈BMD低于TT型和TC型,而绝经后正常妇女三种基因型之间BMD无差异。结论OPG基因T950C基因型分布存在明显的种族差异。OPG基因T950C多态性不能作为中国汉族妇女是否发生骨质疏松症的遗传标志,但对于患有骨质疏松症的中国汉族妇女CC型却能预测骨骨质疏松症的患病程度。 Objective To investigate the relationship among T^950 -C polymorphism genotype in the promoter region of the osteoprotegerin (OPG) gene, osteoporosis and bone metabolism in postmenopausal women. Methods T^950 -C polymorphism genotype was determined by PCR-RFLP in 73 postmenopausal women with osteoporosis and 61 postmenopausal healthy women selected randomly. BMD of lumbar spines and femoral neck, Ward's and trochanteric areas were measured by dual energy X-ray absorptiometry. Bone metabolism indexes were measured by radioimmunoassay. Results The distribution of T^950 -C genotype in OPG gene in the postmenopausal women with osteoporosis and the postmenopausal healthy women accorded with Hardy-Weinberg equilibrium, and there was significant difference between two groups. But there was significant difference in T^950 -C polymorphism genotype between Han nationality women and Caucasia women. In the postmenopausal osteoporosis women, BMD of femoral neck was significantly lower in individuals with CC genotype compared with that in individuals with TT genotype and TC genotype. In the postmenopausal healthy women, BMD were not found significant differences among three genotypes. Conclusions T^950 -C polymorphism genotype distribution of OPG gene had evident race diversity. T^950 -C polymorphism in the promoter region of the osteoprotegerin gene could not be used as genetic marker in predicting whether or not developing osteoporosis in Chinese women of Han nationality, but CC genotype could forecast the suffering degree of the postmenopausal women with osteoporosis of Han nationality.
出处 《中国老年学杂志》 CAS CSCD 北大核心 2005年第3期247-250,共4页 Chinese Journal of Gerontology
基金 广东省科技计划项目基金立项资助(2002B3110102) 广东省医学科学研究基金立项(A2002308)
关键词 护骨素 骨密度 多态性 启动子 基因 点突变 Osteoprotegerin Bone mineral density Polymorphism Promoter Gene Mutation
  • 相关文献

参考文献11

  • 1Simonet WS, Lacey DL, Dunstan CR, et al . Osteoprotegerm: a novel secreted protein involved in the regulation of bone density[J].Cell,1997;589: 309-19.
  • 2Yasuda H, Shima N, Nakagawa N, et al . Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro[J]. Endocrinology,1998;139:1329-37.
  • 3Lacey DL, Timms E, Tan HL, et al . Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation[J].Cell,1998;93:165-76.
  • 4Yasuda H, Shima N, Nakagawa N,et al . Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoelastogenesis-inhibitory factor and is identical to TRANCE/RANKL[J]. Proc Natl Acad Sci USA,1998;95:3597-602.
  • 5Langdahl BL, Carstens M, Stenkjaer L, et al . Polymorphisms in the osteoprotegerin gene are associated with osteoporotic fractures[J]. J Bone Miner Res 2002;17(7): 1245-55.
  • 6Morinaga T, Nakagawa N, Yasuda H, et al . Cloning and characterization of the gene encoding human osteoprotegerin/osteoclastogenesis-inhibitory factor[J].Eur J Biochem,1998;254:685-91.
  • 7Kanis J, Melton I, Christiansen C, et al . The diagnosis of osteoporosis[J].J Bone Miner Res,1994;9:1137-41.
  • 8Morrison NA, Qi JC, Tokita A, et al . Prediction of bone density from vitamin D receptor alleles[J].Nature, 1994;367;284-7.
  • 9Kelly PJ, Morrison NA, Sambrook PN, et al. Genetic influences on bone turnover, bone density and fracture[J].Eur J Endocrinol, 1995;133:265- 71.
  • 10Eisman JA. Genetics of osteoporosis[J].Endocr Rev,1999;20:788-804.

二级参考文献11

  • 1Simonet WS, Lacey DL, Dunstan CR, et al. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell, 1997, 89:309-319.
  • 2Bucay N, Sarosi I, Dunstan CR, et al. Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev,1998,12:1260-1268.
  • 3Morinaga T, Nakagawa N, Yasuda H, et al. Cloning and characterization of the gene encoding human osteoprotegerin/osteoclastogenesis-inhibitory factor. Eur J Biochem,1998,254:685-691.
  • 4Chung H, Hwang C, Kang Y, et al. Osteoprotegerin polymorphism contributes to urine calcium excretion in Korean postmenopausal women. J Bone Miner Res, 2000 ,15(Suppl 1):SU130.
  • 5Wynne F, Drummond F, O′Sullivan K,et al. Investigation of the genetic influence of the OPG,VDR(Fok I),and COLIA I SpI polymorphisms on BMD in the Irish population. Calcif Tissue Int, 2002,71:26-35.
  • 6Brandstrom H, Gerdhem P, Stiger F, et al. Polymorphisms in the genes for vitamin D receptor and osteoprotegerin, relation to bone mineral density in Swedish women aged 75.J Bone Miner Res,2000,15(Suppl 1):SA160.
  • 7Arko B, Prezelj J, Komel R, et al. Sequence variations in the osteoprotegerin gene promoter in patients with postmenopausal osteoporosis. J Clin Endocrinol Metab, 2002,87:4080-4084.
  • 8Langdahl BL, Carstens M, Stenkjar L, et al. Polymorphisms in the osteoprotegerin gene and osteoprotic fractures and bone mass. J Bone Miner Res,2000, 15(Suppl 1):F159.
  • 9Kanis JA. Osteoporosis. 1st ed. Great Britain: Blackwell Science Ltd, 1994. 4.
  • 10Livshits G, Karasik D, Otremski I, et al. Genes play an important role in bone aging. Am J Hum Biol, 1998,10:421-426.

共引文献16

同被引文献153

引证文献13

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部